Professore Ordinario – Dipartimento di Biologia | Tel.: 050 2213697 (lab) 050 2213695 (studio) – Email: arianna.tavanti@unipi.it<\/p>\n","protected":false},"template":"","meta":{"unipi-persone-chiave":"4970","unipi-persone-nome":"Arianna","unipi-persone-cognome":"Tavanti","unipi-persone-email":"arianna.tavanti@unipi.it","unipi-persone-cv":"Prof. Arianna Tavanti, graduated in Biological Sciences in 1995 and was awarded a PhD in Medical and Experimental Microbiology in 2003 from the University of Pisa, Italy. She joined the Department of Molecular and Cell Biology the University of Aberdeen, Scotland UK (2003-04) as Post-Doctoral Research Fellow. She graduated Specialist in Clinical Pathology in 2004 at the University of Pisa.
\r\n
\r\nPostdoctoral research fellow (2005-06) and then permanent Researcher (2006-14) at the Department of Biology, University of Pisa.
\r\n
\r\nDecember 2014-November 2020, Associate Professor of Microbiology;
\r\nSince December 2020 Full Professor of Microbiology at the Department of Biology.
\r\n
\r\nSince November 2019, President of the Biotechnology BSc Degree, University of Pisa and of the Master Degrees in Molecular Biotechnology and Biotechnologies and Applied Artificial Intelligence for Health.
\r\n
\r\nSince November 2021, Coordinator of the PhD Program in Biology, University of Pisa.
\r\n
\r\nMember of the Directive committee of the Italian Society for Human and Animal Mycopathology (FIMUA,2022-today).
\r\n
\r\nMarch 2023-April 2026, member of the Evaluation Committee of the University of Pisa.
\r\n
\r\nHer scientific activity, documented by international publications (93 papers*, H index*: 35, total citations* 4,117 *Scopus https:\/\/www.scopus.com\/authid\/detail.uri?authorId=6602436946) and one book chapter, is mainly focused on:
\r\n
\r\n(i) genetic manipulation of microorganisms (gene deletion and gene editing) as a tool to study microbial virulence and host-pathogen interaction;
\r\n(ii) development of novel diagnostic tools (DNA microarray, CRISPR\/Cas-based sensors) for the detection of microorganisms.
\r\n(iii) study of innovative antimicrobial and antibiofilm strategies (cationic peptides and bacteriophages).
\r\n
\r\nMember of the Editorial Board of Frontiers in Cellular and Infection Microbiology; Journal of Fungi and Journal of Medical Mycology.
\r\n
\r\nCo-recipient of a grant awarded by The Wellcome Trust (ref. SDL\/BEC, 2003-04); Coordinator of the National Project FIRB - Protocol RBFR100FLV (2011-13), of a MIT-UNIPI joined grant (2016-17) and of the Regional Grant CRISPRSENSE (2022-24). Participant of Project T4-AN_07 \u201cPiano Operativo Salute, Traiettoria 4\u201d \u201cHub Multidisciplinare e interregionale di ricerca e sperimentazione clinica per il contrasto alle Pandemie e all\u2019antibiotico resistenza\u201d (2022-24).
\r\nUnit Principal Investigator of the PRIN 2022 \"Innovative mucosal models as prototypes for in depth studies on the pathogenesis of monomicrobial and polymicrobial infections\" Grant Ref no. 2022C7JE2F (2021-2025).","unipi-persone-link-esterno-cv":"","unipi-persone-modalita-ricevimento":"","unipi-persone-luogo-ricevimento":"","unipi-persone-ore-ricevimento":"","unipi-persone-telefono":"050 2213697 (lab) 050 2213695 (studio)","unipi-persone-sitoweb":"","unipi-persone-cariche":"